ALTACE Side Effects

7020546-X | Adrenal Insufficiency, Angioedema, Erythema Nodosum, Rash Maculo-papular
on Sep 20, 2010 Female patient from UNITED STATES , 55 years of age, was diagnosed with prophylaxis, angioedema and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, angioedema, erythema nodosum, rash maculo-papular. Altace dosage: Unk. During the same period patient was treated with TAMIFLU (75 Mg, Bid) (View Tamiflu Review and Tamiflu Label ), PREDNISONE (7.5 Mg, Unk) (View Prednisone Review and Prednisone Label ), LANTUS (View Lantus Review and Lantus Label ), XYZAL (View Xyzal Review and Xyzal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

7020543-4 | Abdominal Pain Upper, Dizziness, Dyspepsia, Electrolyte Imbalance, Hypokalaemia, Hypotension, Loss Of Consciousness, Nausea, Tremor
Patient was taking Altace (View Usage). Patient had the following side effects: abdominal pain upper, dizziness (What is dizziness?), dyspepsia, electrolyte imbalance, hypokalaemia, hypotension, loss of consciousness, nausea (What is nausea?), tremor on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 229.0 lb, was diagnosed with blood pressure management, acute myocardial infarction, catheterisation cardiac, thrombosis prophylaxis, peritoneal dialysis and. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with HEPARIN SODIUM (1.5 Ml, Prn) (View Heparin Sodium Review and Heparin Sodium Label ), TOPROL XL (50 Mg, Qd) (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

7018291-X | Diarrhoea, Dysentery
Adverse event was reported on Sep 17, 2010 by a Female patient taking Altace (View Usage) (Dosage: 5 Mg, Single) . Location: ITALY , 68 years of age, After Altace was administered, patient had the following side effects: diarrhoea, dysentery. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, Single) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LANSOPRAZOLE (2 U, Single) (View Lansoprazole Review and Lansoprazole Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ASPIRIN (500 Mg, Qd) (View Aspirin Review and Aspirin Label ), SEQUACOR (View Sequacor Review and Sequacor Label ). Patient was hospitalized.

7013406-1 | Asthenia, Blood Pressure Systolic Decreased, Bradyarrhythmia, Hyperkalaemia, Hyponatraemia, Listless, Nausea, Syncope
on Sep 15, 2010 Female patient from GERMANY , 80 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood pressure systolic decreased, bradyarrhythmia, hyperkalaemia, hyponatraemia, listless, nausea (What is nausea?), syncope. Altace dosage: 5 Mg, Bid. During the same period patient was treated with FELODIPINE (5 Mg, Bid) (View Felodipine Review and Felodipine Label ), ALDACTONE (50 Mg, Qd) (View Aldactone Review and Aldactone Label ), METOPROLOL SUCCINATE (95 Mg, Bid) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), MOXONIDINE (0.4 Mg, Bid) (View Moxonidine Review and Moxonidine Label ), DIGITOXIN (Unk) (View Digitoxin Review and Digitoxin Label ), FERROUS SULFATE (Unk) (View Ferrous Sulfate Review and Ferrous Sulfate Label ). Patient was hospitalized.


7013405-X | Anaemia Macrocytic, Cough
on Sep 17, 2010 Male patient from FRANCE , 84 years of age, was diagnosed with hypertension, cough and was treated with Altace (View Usage). Patient had the following side effects: anaemia macrocytic, cough. Altace dosage: 1.25 Mg, Qd. During the same period patient was treated with OXOMEMAZINE (Unk) (View Oxomemazine Review and Oxomemazine Label ), ESOMEPRAZOLE MAGNESIUM (40 Mg, Qd) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ALLOPURINOL (200 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), LASIX (View Lasix Review and Lasix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), UMULINE (View Umuline Review and Umuline Label ), NITRODERM (Unk) (View Nitroderm Review and Nitroderm Label ), EFFERALGAN (Unk) (View Efferalgan Review and Efferalgan Label ).

7009339-7 | Coma, Dehydration, Diarrhoea, Heart Rate Increased, Hyperkalaemia, Hypotension, Renal Failure, Syncope
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: coma, dehydration, diarrhoea, heart rate increased, hyperkalaemia, hypotension, renal failure, syncope on Sep 15, 2010 from GERMANY Additional patient health information: Male patient , 78 years of age, was diagnosed with constipation (What is constipation?), dementia alzheimer's type, coronary artery disease (What is coronary artery disease?), gastritis erosive and. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with DULCOLAX (5 Mg, Qd) (View Dulcolax Review and Dulcolax Label ), MEMANTINE HCL (10 Mg, Bid) (View Memantine Hcl Review and Memantine Hcl Label ), ACETYLSALICYLIC ACID (100 Mg, Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BISOPROLOL FUMARATE (2.5 Mg, Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ESOMEPRAZOLE MAGNESIUM (20 Mg, Unk) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), RISPERIDONE (2.5 Mg, Unk) (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

7009337-3 | Blood Pressure Systolic Increased, Headache, Hypertensive Crisis
Adverse event was reported on Sep 15, 2010 by a Female patient taking Altace (View Usage) (Dosage: 10 Mg, Qd) . Location: GERMANY , 62 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, headache (What is headache?), hypertensive crisis.

6987143-3 | Bradycardia, Bronchitis Haemophilus, Cardiac Tamponade, Cholestasis, Cytolytic Hepatitis, Extrasystoles, Haemodynamic Instability, Hepatocellular Injury
on Sep 07, 2010 Male patient from FRANCE , 55 years of age, was diagnosed with cholestasis and was treated with Altace (View Usage). Patient had the following side effects: bradycardia, bronchitis haemophilus, cardiac tamponade, cholestasis, cytolytic hepatitis, extrasystoles, haemodynamic instability, hepatocellular injury. Altace dosage: 1.25 Mg, Bid. During the same period patient was treated with PRIMPERAN TAB (10 Mg, Single) (View Primperan Tab Review and Primperan Tab Label ), TERCIAN (10 Mg, Qid) (View Tercian Review and Tercian Label ), DIPRIVAN (Unk, Qd) (View Diprivan Review and Diprivan Label ), ESOMEPRAZOLE MAGNESIUM (Unk, Qd) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), CRESTOR (5 Mg, Qd) (View Crestor Review and Crestor Label ), HEPARIN SODIUM (Unk, Qd) (View Heparin Sodium Review and Heparin Sodium Label ), ERYTHROMYCIN (200 Mg, Single) (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

6987142-1 | Blood Creatine Phosphokinase Increased, Confusional State, Miosis, Narcotic Intoxication, Renal Impairment, Somnolence
on Sep 10, 2010 Male patient from UNITED KINGDOM , 79 years of age, was diagnosed with hypertension, left ventricular failure, fluid overload, diabetes mellitus, hypercholesterolaemia, polyuria, phantom pain, breakthrough pain and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: blood creatine phosphokinase increased, confusional state, miosis, narcotic intoxication, renal impairment, somnolence. Altace dosage: 7.5 Mg, Qd. During the same period patient was treated with FRUSEMIDE (40 Mg, Qd) (View Frusemide Review and Frusemide Label ), METFORMIN (500 Mg, Tid) (View Metformin Review and Metformin Label ), ATORVASTATIN (20 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), OXYCONTIN (40 Mg, Bid) (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (10 Mg, Tid Or Qid) (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6987141-X | Bradycardia, Malaise
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, malaise on Sep 06, 2010 from FINLAND Additional patient health information: Female patient , 82 years of age, was diagnosed with dementia alzheimer's type and. Altace dosage: Unk. During the same period patient was treated with BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ARICEPT (Unk) (View Aricept Review and Aricept Label ), TAHOR (Unk) (View Tahor Review and Tahor Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6980387-6 | Asthenia, Dizziness, Fall, Feeling Abnormal, Hyponatraemia, Nausea, Presyncope, Tinnitus
Adverse event was reported on Sep 07, 2010 by a Female patient taking Altace (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with hypertension, angiopathy, osteoporosis (What is osteoporosis?) and. Location: GERMANY , 85 years of age, Patient had the following side effects: asthenia, dizziness (What is dizziness?), fall (What is fall?), feeling abnormal, hyponatraemia, nausea (What is nausea?), presyncope, tinnitus (What is tinnitus?). During the same period patient was treated with BELOC ZOC COMP (1 Df, Qd) (View Beloc-zoc Comp Review and Beloc-zoc Comp Label ), HEXAL (100 Mg, Unk) (View Hexal Review and Hexal Label ), VALIUM (500 Mg, Unk) (View Valium Review and Valium Label ), FOSAMAX (70 Mg, Unk) (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6980386-4 | Hyperkalaemia, Oxygen Saturation Decreased, Pulmonary Embolism, Tachycardia
on Sep 03, 2010 Female patient from FRANCE , 73 years of age, was diagnosed with thrombosis prophylaxis and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: hyperkalaemia, oxygen saturation decreased, pulmonary embolism (What is pulmonary embolism?), tachycardia. Altace dosage: Unk. During the same period patient was treated with ENOXAPARIN SODIUM (Unk) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), APIXABAN (2 Df, Qd) (View Apixaban Review and Apixaban Label ), IPRATROPIUM BROMIDE (Unk) (View Ipratropium Bromide Review and Ipratropium Bromide Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ), NOVONORM (Unk) (View Novonorm Review and Novonorm Label ), ELATROLET (Unk) (View Elatrolet Review and Elatrolet Label ). Patient was hospitalized.

6978197-9 | Arthropathy, Ecchymosis, Mobility Decreased
on Sep 03, 2010 Female patient from ITALY , 72 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy, ecchymosis, mobility decreased. Altace dosage: 5 Mg, Qd. During the same period patient was treated with TICLOPIDINE HYDROCHLORIDE (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CANRENONE (View Canrenone Review and Canrenone Label ).

6978194-3 | Angina Unstable, Atrial Fibrillation, Cardiac Failure, Dizziness, Dyspnoea, Hypotension
Patient was taking Altace (View Usage). Patient had the following side effects: angina unstable, atrial fibrillation (What is atrial fibrillation?), cardiac failure, dizziness (What is dizziness?), dyspnoea, hypotension on Sep 02, 2010 from HONG KONG Additional patient health information: Male patient , 75 years of age, was diagnosed with cardiac failure and. Altace dosage: Unk. During the same period patient was treated with DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), ESOMEPRAZOLE MAGNESIUM (Unk) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), SINEMET (Unk) (View Sinemet Review and Sinemet Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), WARFARIN (Unk) (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6963773-X | Abdominal Discomfort, Balance Disorder, Blood Creatine Increased, Fall, Renal Failure Acute, Therapeutic Agent Toxicity
Adverse event was reported on Aug 27, 2010 by a Male patient taking Altace (View Usage) (Dosage: 2.5 Mg, Bid) was diagnosed with hypertension, schizoaffective disorder and. Location: GERMANY , 60 years of age, After Altace was administered, patient had the following side effects: abdominal discomfort, balance disorder, blood creatine increased, fall (What is fall?), renal failure acute, therapeutic agent toxicity. During the same period patient was treated with LITHIUM CARBONATE (450 Mg, Qd) (View Lithium Carbonate Review and Lithium Carbonate Label ), METFORMIN (Unk) (View Metformin Review and Metformin Label ), METOPROLOL SUCCINATE (Unk) (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

6963772-8 | Fall, Head Injury, Muscular Weakness, Transient Ischaemic Attack
on Aug 25, 2010 Female patient from ITALY , 87 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), head injury, muscular weakness, transient ischaemic attack. Altace dosage: Unk. During the same period patient was treated with ALDACTONE (25 Mg, Qd) (View Aldactone Review and Aldactone Label ), COUMADIN (5 Mg, Qd) (View Coumadin Review and Coumadin Label ), LASIX (50 Mg, Qd) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6942704-2 | Agranulocytosis, Infection, Lung Infection Pseudomonal, Thrombosis
on Aug 19, 2010 Male patient from CANADA , 79 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). Patient had the following side effects: agranulocytosis, infection (What is infection?), lung infection pseudomonal, thrombosis. Altace dosage: Unk. Patient was hospitalized.

6939310-2 | Abdominal Hernia, Anhedonia, Asthenia, Bronchitis, Cough, Dyspnoea, Lethargy, Malaise
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: abdominal hernia, anhedonia, asthenia, bronchitis (What is bronchitis?), cough, dyspnoea, lethargy, malaise on Aug 18, 2010 from CANADA Additional patient health information: Male patient , 59 years of age, was diagnosed with hypertension, diabetes mellitus, chronic obstructive pulmonary disease and. Altace dosage: 5 Mg, Qd. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ). Patient was hospitalized and became disabled.

6939305-9 | Bradycardia, Cardiac Output Decreased, Hyperkalaemia, Renal Failure Acute
Adverse event was reported on Aug 19, 2010 by a Male patient taking Altace (View Usage) (Dosage: 2.5 Mg, Qd) . Location: SWEDEN , 73 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac output decreased, hyperkalaemia, renal failure acute. During the same period patient was treated with COAPROVEL (150/12.5 Mg, Qd) (View Coaprovel Review and Coaprovel Label ), LACEROL (120 Mg, Qd) (View Lacerol Review and Lacerol Label ), MANIDIPINE HYDROCHLORIDE (20 Mg, Qd) (View Manidipine Hydrochloride Review and Manidipine Hydrochloride Label ), EMCONCOR COR (2.5 Mg, Qd) (View Emconcor Cor Review and Emconcor Cor Label ), CARDYL (40 Mg, Qd) (View Cardyl Review and Cardyl Label ), CARDURA (4 Mg, Qd) (View Cardura Review and Cardura Label ), ISCOVER (75 Mg, Qd) (View Iscover Review and Iscover Label ), HEMOVAS (600 Mg, Bid) (View Hemovas Review and Hemovas Label ). Patient was hospitalized.

6931505-7 | Atrioventricular Block Complete, Chest Pain, Dyspnoea, Fatigue, Hyperkalaemia, Renal Failure
on Aug 12, 2010 Male patient from FRANCE , 80 years of age, was diagnosed with hypertension, cardiac failure, angina pectoris and was treated with Altace (View Usage). Patient had the following side effects: atrioventricular block complete, chest pain (What is chest pain?), dyspnoea, fatigue, hyperkalaemia, renal failure. Altace dosage: 5 Mg, Qd. During the same period patient was treated with SPIRONOLACTONE (25 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), BISOPROLOL FUMARATE (2.5 Mg, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), VASODILATORS USED IN CARDIAC DISEASES (5 Mg, Bid) (View Vasodilators Used In Cardiac Diseases Review and Vasodilators Used In Cardiac Diseases Label ), FUROSEMIDE (40 Mg, Unk) (View Furosemide Review and Furosemide Label ), ATORVASTATIN CALCIUM (20 Mg, Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PREVISCAN (20 Mg, Unk) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6929840-1 | Cerebral Disorder, Dysarthria, Hypotension, Syncope
on Aug 05, 2010 Female patient from GERMANY , 77 years of age, was diagnosed with hypertension, sleep disorder (What is sleep disorder?) and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: cerebral disorder, dysarthria, hypotension, syncope. Altace dosage: 5 Mg, Bid. During the same period patient was treated with PROTHIPENDYL (80 Mg, Qhs) (View Prothipendyl Review and Prothipendyl Label ), AMLODIPINE (5 Mg, Qam) (View Amlodipine Review and Amlodipine Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6929761-4 | Cerebral Disorder, Dysarthria, Hypotension, Syncope
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral disorder, dysarthria, hypotension, syncope on Aug 06, 2010 from GERMANY Additional patient health information: Female patient , 77 years of age, was diagnosed with hypertension, sleep disorder (What is sleep disorder?) and. Altace dosage: 5 Mg, Bid. During the same period patient was treated with PROTHIPENDYL (80 Mg, Qhs) (View Prothipendyl Review and Prothipendyl Label ), AMLODIPINE (5 Mg, Qam) (View Amlodipine Review and Amlodipine Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6924992-1 | Depressed Mood, Dyspnoea, Headache, Heart Rate Decreased, Insomnia, Lethargy, Malaise, Palpitations
Adverse event was reported on Aug 10, 2010 by a Female patient taking Altace (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with renal failure chronic, atrial fibrillation (What is atrial fibrillation?), dyspepsia and. Location: UNITED KINGDOM , 62 years of age, Patient had the following side effects: depressed mood, dyspnoea, headache (What is headache?), heart rate decreased, insomnia, lethargy, malaise, palpitations. During the same period patient was treated with FLECAINIDE ACETATE (100 Mg, Bid) (View Flecainide Acetate Review and Flecainide Acetate Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), NULYTELY (Unk) (View Nulytely Review and Nulytely Label ), OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ).

6924991-X | Anaemia, Blood Creatinine Increased, Blood Urea Increased, Haematoma, International Normalised Ratio Increased, Oedema Peripheral, Overdose, Pulmonary Embolism, Renal Failure Acute
on Aug 06, 2010 Female patient from FRANCE , 96 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: anaemia, blood creatinine increased, blood urea increased, haematoma, international normalised ratio increased, oedema peripheral, overdose, pulmonary embolism (What is pulmonary embolism?), renal failure acute. Altace dosage: 1.25 Mg, Qd. During the same period patient was treated with ATENOLOL (Unk) (View Atenolol Review and Atenolol Label ), AMLOR (Unk) (View Amlor Review and Amlor Label ), ZOLOFT (Unk) (View Zoloft Review and Zoloft Label ), COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), NORFLOXACIN (Unk) (View Norfloxacin Review and Norfloxacin Label ). Patient was hospitalized.

6924989-1 | Arrhythmia, Blood Creatinine Increased, Bradycardia, Dyspnoea, Fatigue, Pyrexia
on Aug 06, 2010 Female patient from SWEDEN , 76 years of age, was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), blood creatinine increased, bradycardia, dyspnoea, fatigue, pyrexia. Altace dosage: 1 Df, Qd. During the same period patient was treated with METOZOK (25 Mg, Qd) (View Metozok Review and Metozok Label ), DIGOXIN (0.13 Mg, Qd) (View Digoxin Review and Digoxin Label ), BRIMONIDINE (View Brimonidine Review and Brimonidine Label ), TIMOLOL (View Timolol Review and Timolol Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ). Patient was hospitalized.

6922889-4 | Cardiac Failure, Hypokalaemia, Restlessness, Sleep Phase Rhythm Disturbance, Tachyarrhythmia, Urethral Haemorrhage, Urethral Injury, Ventricular Fibrillation, Ventricular Flutter
Patient was taking Altace (View Usage). Patient had the following side effects: cardiac failure, hypokalaemia, restlessness, sleep phase rhythm disturbance, tachyarrhythmia, urethral haemorrhage, urethral injury, ventricular fibrillation, ventricular flutter on Aug 04, 2010 from GERMANY Additional patient health information: Male patient , 80 years of age, . Altace dosage: 5 Mg, Qd. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TRUXAL (60 Mg, Qd) (View Truxal Review and Truxal Label ), METOPROLOL TARTRATE (25 Mg, Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MOLSIDOMINE (24 Mg, Qd) (View Molsidomine Review and Molsidomine Label ), SPASMEX (15 Mg, Qd) (View Spasmex Review and Spasmex Label ), TORSEMIDE (20 Mg, Qd) (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6922887-0 | Anuria, Asthenia, Blood Creatinine Increased, Blood Potassium Increased, Bradycardia, Renal Failure Acute, Vomiting
Adverse event was reported on Aug 04, 2010 by a Male patient taking Altace (View Usage) (Dosage: Unk) . Location: FRANCE , 79 years of age, After Altace was administered, patient had the following side effects: anuria, asthenia, blood creatinine increased, blood potassium increased, bradycardia, renal failure acute, vomiting. During the same period patient was treated with DIGITALINE NATIVELLE (0.25 Mg, Qd) (View Digitaline Nativelle Review and Digitaline Nativelle Label ), LASIX (View Lasix Review and Lasix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6918598-8 | Acute Prerenal Failure, Bradycardia, Dehydration, Hypotension
on Aug 04, 2010 Female patient from FRANCE , 91 years of age, was diagnosed with acute coronary syndrome and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, bradycardia, dehydration, hypotension. Altace dosage: 1.25 Mg, Single. During the same period patient was treated with BISOPROLOL FUMARATE (2.5 Mg, Single) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), ATHYMIL (Unk) (View Athymil Review and Athymil Label ), TAHOR (Unk) (View Tahor Review and Tahor Label ). Patient was hospitalized.

6915683-1 | Altered State Of Consciousness, Bradycardia, Cardiac Output Decreased, Cardiogenic Shock, Confusional State, Ejection Fraction Decreased, Electrocardiogram P Wave Abnormal, Electrocardiogram Qrs Complex Abnormal, Electrocardiogram T Wave Abnormal
on Jul 28, 2010 Male patient from NORWAY , 75 years of age, was diagnosed with cardiac failure and was treated with Altace (View Usage). Patient had the following side effects: altered state of consciousness, bradycardia, cardiac output decreased, cardiogenic shock, confusional state, ejection fraction decreased, electrocardiogram p wave abnormal, electrocardiogram qrs complex abnormal, electrocardiogram t wave abnormal. Altace dosage: 10 Mg, Qam. During the same period patient was treated with METOPROLOL (100 Mg, Qam) (View Metoprolol Review and Metoprolol Label ), SPIRONOLACTONE (25 Mg, Qam) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (50 Mcg, Qam) (View Digoxin Review and Digoxin Label ), BUMETANIDE (1.5 Mg, Qam) (View Bumetanide Review and Bumetanide Label ). Patient was hospitalized.

6915651-X | Blood Creatine Phosphokinase Increased, Confusional State, Miosis, Narcotic Intoxication, Renal Impairment, Somnolence
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: blood creatine phosphokinase increased, confusional state, miosis, narcotic intoxication, renal impairment, somnolence on Jul 29, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 79 years of age, was diagnosed with hypertension, left ventricular failure, fluid overload, diabetes mellitus, hypercholesterolaemia, polyuria, phantom pain, breakthrough pain and. Altace dosage: 7.5 Mg, Qd. During the same period patient was treated with FRUSEMIDE (40 Mg, Qd) (View Frusemide Review and Frusemide Label ), METFORMIN HCL (500 Mg, Tid) (View Metformin Hcl Review and Metformin Hcl Label ), ATORVASTATIN (20 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), OXYCONTIN (40 Mg, Bid) (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (10 Mg, Tid Or Qid) (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6915650-8 | Gait Disturbance, Hypoaesthesia, Peroneal Nerve Palsy
Adverse event was reported on Aug 03, 2010 by a Male patient taking Altace (View Usage) (Dosage: Unk) . Location: GERMANY , 49 years of age, Patient experienced the following unwanted or unexpected effects: gait disturbance, hypoaesthesia, peroneal nerve palsy.

6911609-5 | Confusional State
on Jul 29, 2010 Male patient from FRANCE , 89 years of age, was treated with Altace (View Usage). Patient had the following side effects: confusional state. Altace dosage: 1.25 Mg, Qd. During the same period patient was treated with EQUANIL (3 Df, Qd) (View Equanil Review and Equanil Label ), OXYCODONE HCL (10 Mg, Qd) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCONTIN (20 Mg, Qd) (View Oxycontin Review and Oxycontin Label ), DUPHALAC (2 Tbsp, Unk) (View Duphalac Review and Duphalac Label ), CEFTRIAXONE (1 G, Qd) (View Ceftriaxone Review and Ceftriaxone Label ), CORDARONE (View Cordarone Review and Cordarone Label ), COZAAR (View Cozaar Review and Cozaar Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6911608-3 | Blood Creatinine Increased, Bradycardia, Hyperkalaemia
on Aug 02, 2010 Female patient from SWEDEN , 75 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: blood creatinine increased, bradycardia, hyperkalaemia. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), SIMVASTATIN ACO (View Simvastatin Aco Review and Simvastatin Aco Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DUROFERON (View Duroferon Review and Duroferon Label ), FURIX (View Furix Review and Furix Label ), TROMBYL (View Trombyl Review and Trombyl Label ), STILNOCT (View Stilnoct Review and Stilnoct Label ). Patient was hospitalized.

6911607-1 | Blood Pressure Systolic Decreased, Hyponatraemia, Malaise, Troponin Increased
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic decreased, hyponatraemia, malaise, troponin increased on Jul 30, 2010 from FRANCE Additional patient health information: Female patient , 84 years of age, was diagnosed with hypertension, hyperuricaemia, atrial fibrillation (What is atrial fibrillation?) and. Altace dosage: Unk. During the same period patient was treated with ROSUVASTATIN CALCIUM (5 Mg, Qd) (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), CORDARONE (200 Mg, Qd) (View Cordarone Review and Cordarone Label ), PREVISCAN (20 Mg, Qd) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6908987-X | Blood Creatinine Increased, Dyspnoea, Intra-abdominal Haematoma, Oedema Peripheral, Renal Failure Acute
Adverse event was reported on Jul 28, 2010 by a Female patient taking Altace (View Usage) (Dosage: Unk) . Location: FRANCE , 64 years of age, Patient had the following side effects: blood creatinine increased, dyspnoea, intra-abdominal haematoma, oedema peripheral, renal failure acute. During the same period patient was treated with LASIX (40 Mg, Bid) (View Lasix Review and Lasix Label ), ULTRAVIST 150 (Unk) (View Ultravist 150 Review and Ultravist 150 Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), PREVISCAN (View Previscan Review and Previscan Label ), SINGULAIR (View Singulair Review and Singulair Label ), LERCAN (View Lercan Review and Lercan Label ). Patient was hospitalized.

6899868-9 | Biliary Colic, Gallbladder Pain
on Jul 26, 2010 Female patient from UNITED KINGDOM , 37 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: biliary colic, gallbladder pain. Altace dosage: 1.25 Mg, Unk. During the same period patient was treated with BENDROFLUMETHIAZIDE (Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ).

6894302-7 | Dysarthria, Fall, Hypotension, Syncope
on Jul 20, 2010 Female patient from GERMANY , 77 years of age, was diagnosed with hypertension, sleep disorder (What is sleep disorder?) and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, fall (What is fall?), hypotension, syncope. Altace dosage: 5 Mg, Bid. During the same period patient was treated with PROTHIPENDYL (80 Mg, Qhs) (View Prothipendyl Review and Prothipendyl Label ), AMLODIPINE (5 Mg, Qam) (View Amlodipine Review and Amlodipine Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), BAYOTENSIN AKUT (Unk) (View Bayotensin Akut Review and Bayotensin Akut Label ), PREGABALIN (150 Mg, Qd) (View Pregabalin Review and Pregabalin Label ).

6894301-5 | Ammonia Increased, Electroencephalogram Abnormal, Hepatic Encephalopathy, Loss Of Consciousness
Patient was taking Altace (View Usage). Patient had the following side effects: ammonia increased, electroencephalogram abnormal, hepatic encephalopathy, loss of consciousness on Jul 26, 2010 from FRANCE Additional patient health information: Male patient , 40 years of age, was diagnosed with portal hypertension, proteinuria, haemorrhage prophylaxis, glomerulonephritis membranous and. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with LOSARTAN POTASSIUM (50 Mg, Qd) (View Losartan Potassium Review and Losartan Potassium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), FUROSEMIDE (125 Mg, Qd) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6880370-5 | Atrioventricular Block First Degree, Bundle Branch Block Left, Dizziness, Hyperkalaemia, Hypotension, Infection, Loss Of Consciousness, Supraventricular Extrasystoles, Syncope
Adverse event was reported on Jul 20, 2010 by a Female patient taking Altace (View Usage) (Dosage: 5 Mg, Bid) was diagnosed with hypertension, platelet aggregation inhibition, diabetic neuropathy and. Location: GERMANY , 75 years of age, After Altace was administered, patient had the following side effects: atrioventricular block first degree, bundle branch block left, dizziness (What is dizziness?), hyperkalaemia, hypotension, infection (What is infection?), loss of consciousness, supraventricular extrasystoles, syncope. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, Bid) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), KARVEA (1 Df, Qd) (View Karvea Review and Karvea Label ), ACETYLSALICYLIC ACID SRT (100 Mg, Unk) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), AMLODIPINE (20 Mg, Bid) (View Amlodipine Review and Amlodipine Label ), FUROSEMIDE (40 Mg, Unk) (View Furosemide Review and Furosemide Label ), GABAPENTIN (400 Mg, Qid) (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6880369-9 | Abdominal Hernia, Activities Of Daily Living Impaired, Anhedonia, Asthenia, Bronchitis, Cough, Dyspnoea, Fatigue, Lethargy
on Jul 19, 2010 Male patient from CANADA , 59 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal hernia, activities of daily living impaired, anhedonia, asthenia, bronchitis (What is bronchitis?), cough, dyspnoea, fatigue, lethargy. Altace dosage: Unk. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PROTON PUMP INHIBITORS (View Proton Pump Inhibitors Review and Proton Pump Inhibitors Label ). Patient was hospitalized and became disabled.

6880365-1 | Aphasia, Brain Oedema, Cerebral Haematoma, Convulsion, Headache, Hemianopia, Hemiparesis
on Jul 21, 2010 Female patient from FRANCE , 56 years of age, was diagnosed with myocardial infarction and was treated with Altace (View Usage). Patient had the following side effects: aphasia (What is aphasia?), brain oedema, cerebral haematoma, convulsion, headache (What is headache?), hemianopia, hemiparesis. Altace dosage: Unk. During the same period patient was treated with COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), KARDEGIC (75 Mg, Unk) (View Kardegic Review and Kardegic Label ), TAHOR (Unk) (View Tahor Review and Tahor Label ), PANTOPRAZOLE SODIUM (Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), TENORMIN (Unk) (View Tenormin Review and Tenormin Label ), LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6880363-8 | Dehydration, Dysphagia, Renal Failure Acute, Weight Decreased
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: dehydration, dysphagia, renal failure acute, weight decreased on Jul 16, 2010 from FRANCE Additional patient health information: Male patient , 70 years of age, was diagnosed with hypertension and. Altace dosage: 2.5 Mg, Bid. During the same period patient was treated with BISOPROLOL FUMARATE (10 Mg, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), KARDEGIC (160 Mg, Qd) (View Kardegic Review and Kardegic Label ), NEXIUM (20 Mg, Qd) (View Nexium Review and Nexium Label ), CRESTOR (20 Mg, Qd) (View Crestor Review and Crestor Label ), FORTIMEL (Unk) (View Fortimel Review and Fortimel Label ), IMOVANE (Unk) (View Imovane Review and Imovane Label ), FORLAX (4000 Unk, Prn) (View Forlax Review and Forlax Label ). Patient was hospitalized.

6880360-2 | Bradycardia, Cardiac Output Decreased, Cardiogenic Shock, Confusional State, Electrocardiogram Qrs Complex Abnormal, Electrocardiogram T Wave Abnormal, Hyperkalaemia, Hypotension, Hypovolaemia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Altace (View Usage) (Dosage: 1.25 Mg, Qd) was diagnosed with cardiac failure and. Location: NORWAY , 75 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac output decreased, cardiogenic shock, confusional state, electrocardiogram qrs complex abnormal, electrocardiogram t wave abnormal, hyperkalaemia, hypotension, hypovolaemia. During the same period patient was treated with METOPROLOL TARTRATE (100 Mg, Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SPIRONOLACTONE (Unk) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ). Patient was hospitalized.

6880359-6 | Myelodysplastic Syndrome
on Jul 19, 2010 Male patient from GERMANY , 80 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). Patient had the following side effects: myelodysplastic syndrome. Altace dosage: 5 Mg, Qd. During the same period patient was treated with ISCOVER (View Iscover Review and Iscover Label ), DIBLOCIN PP (View Diblocin Pp Review and Diblocin Pp Label ), INSULIN ACTRAPHANE (View Insulin Actraphane Review and Insulin Actraphane Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6862513-2 | Angioedema, Facial Pain, Hypersensitivity, Lip Swelling, Nasal Congestion, Nasal Oedema, Swelling Face
on Jul 13, 2010 Female patient from UNITED KINGDOM , 42 years of age, weighting 233.6 lb, was diagnosed with hypertension, anaemia and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: angioedema, facial pain, hypersensitivity, lip swelling, nasal congestion, nasal oedema, swelling face. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with CALCIUM CARBONATE (1.25 G, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ), FERROUS SULFATE TAB (200 Mg, Qd) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ). Patient was hospitalized.

6862511-9 | Amnesia, Diarrhoea Haemorrhagic, Haemorrhage, Normochromic Normocytic Anaemia, Psychomotor Retardation, Renal Failure Acute
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, diarrhoea haemorrhagic, haemorrhage, normochromic normocytic anaemia, psychomotor retardation, renal failure acute on Jul 09, 2010 from FRANCE Additional patient health information: Male patient , 61 years of age, was diagnosed with hypertension and. Altace dosage: 5 Mg, Qd. During the same period patient was treated with LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ), MYFORTIC (360 Mg, Bid) (View Myfortic Review and Myfortic Label ), TARDYFERON B9 (2 Df, Unk) (View Tardyferon B9 Review and Tardyferon B9 Label ), SODIUM BICARBONATE (1 G, Q4h) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), EUPRESSYL (60 Mg, Tid) (View Eupressyl Review and Eupressyl Label ), AMLOR (10 Mg, Qd) (View Amlor Review and Amlor Label ), AVLOCARDYL (160 Mg, Qd) (View Avlocardyl Review and Avlocardyl Label ), LESCOL (40 Mg, Qd) (View Lescol Review and Lescol Label ). Patient was hospitalized.

6862509-0 | Agranulocytosis, Infection, Lung Infection Pseudomonal, Thrombosis
Adverse event was reported on Jul 09, 2010 by a Male patient taking Altace (View Usage) (Dosage: Unk) was diagnosed with hypertension and. Location: CANADA , 79 years of age, Patient had the following side effects: agranulocytosis, infection (What is infection?), lung infection pseudomonal, thrombosis. Patient was hospitalized.

6857274-7 | Cytolytic Hepatitis, Rhabdomyolysis
on Jul 09, 2010 Male patient from FRANCE , 81 years of age, was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: cytolytic hepatitis, rhabdomyolysis. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with TAHOR (40 Mg, Qd) (View Tahor Review and Tahor Label ), PRASUGREL (Unk) (View Prasugrel Review and Prasugrel Label ). Patient was hospitalized.

6847580-4 | Anaemia, Crepitations, Dehydration, Diarrhoea, Dry Mouth, Hyperkalaemia, Lactic Acidosis, Renal Failure Acute, Tachypnoea
on Jul 12, 2010 Female patient from FRANCE , 83 years of age, was diagnosed with hypertension, type 2 diabetes mellitus and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, crepitations, dehydration, diarrhoea, dry mouth, hyperkalaemia, lactic acidosis, renal failure acute, tachypnoea. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ), GLUCOPHAGE (850 Mg, Tid) (View Glucophage Review and Glucophage Label ), ASPEGIC 1000 (Unk) (View Aspegic 1000 Review and Aspegic 1000 Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), CARDENSIEL (Unk) (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

6847579-8 | Blood Glucose Increased, Pain In Extremity, Tendon Rupture
Patient was taking Altace (View Usage). Patient had the following side effects: blood glucose increased, pain in extremity, tendon rupture on Jul 08, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 240.0 lb, was diagnosed with diabetes mellitus, localised infection and. Altace dosage: 5 Mg, Qd. During the same period patient was treated with LEVAQUIN (500 Mg, Bid) (View Levaquin Review and Levaquin Label ), INSULIN DETEMIR (Unk, Daily) (View Insulin Detemir Review and Insulin Detemir Label ).